# Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss

> **NCT00779519** · PHASE2 · COMPLETED · sponsor: **vTv Therapeutics** · enrollment: 100 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** TTP435
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00779519
- **Lead sponsor:** vTv Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00779519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00779519, "Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00779519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*